Top Markets
Coin of the day
Elicio Therapeutics, Inc. Elicio Therapeutics, Inc.

Elicio Therapeutics, Inc.

ELTX
Kedudukan dalam Saham #24601
Elicio Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to... Elicio Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to creating a diverse array of innovative immunotherapies for the treatment of various cancers and other diseases. The company's primary experimental drug, ELI-002, is an AMP therapeutic vaccine specifically formulated to target KRAS-driven cancers. Its development portfolio also encompasses ELI-004, an AMP-modified CpG adjuvant that forms part of ELI-002; ELI-007, a lymph node-targeted AMP-peptide vaccine addressing mutant BRAF-driven cancers; and ELI-008, a multivalent lymph node-targeted AMP-peptide vaccine for cancers expressing mutant TP53. Furthermore, Elicio is advancing ELI-005, a vaccine candidate for preventing COVID-19, and ELI-011 for hematological malignancies. Another program, ELI-012, is an mKRAS TCR T cell AMP-lifier designed for combined use with mKRAS-targeted TCR T cell therapy against mKRAS-driven cancers. The company's operations are headquartered in Boston, Massachusetts.
Harga Saham
$3.09
Modal Pasaran
$58.82M
Perubahan (1 hari)
0.33%
Perubahan (1 tahun)
-73.01%
Negara
US
Perdagangan Elicio Therapeutics, Inc. (ELTX)

Kategori

Sejarah pecahan saham untuk Elicio Therapeutics, Inc. (ELTX)
Saham Elicio Therapeutics, Inc. (simbol: ELTX) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Aug 21, 2026.
Satu saham ELTX yang dibeli sebelum Aug 21, 2026 kini bersamaan dengan 0 saham ELTX.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH